Duncan Bucknell

Jeremy Phillips, Duncan Bucknell and Jose Carlos Vaz e Dias discuss pharmaceutical and biological data exclusivity in the United States and Brazil, Geographical Indications in Europe and Brazil, European Court of...

Jeremy Phillips and Duncan Bucknell discuss the rise and rise of the Pirate Party in Europe and future implications, the demise of Loi Hadopi, and seizure of generic drugs transitng through...

Gene Quinn over at IP Watchdog is doing a survey to see what people say are the top patent blogs.  We’re delighted to be included in the list, but we’re not...

In this presentation Duncan reviews the current contentious strategic approach to intellectual property in the pharmaceutical industry.  He then looks at the fast paced change that is already overwhelming some parts...

The cheapest way to invalidate a patent is to just watch it and let it lapse.  Half of all US patents will lapse at the 12 year mark, and the number...

Duncan speaks to Gregory Glover, a panellist at the 2009 BIO International Convention, about the pending Biosimilar legislation

Jeremy Phillips, Hal Wegner and Duncan Bucknell discuss patent reform in the US, patent harmonisation and patent damages, the economic crisis and intellectual property practice, and some solutions to the overabundance...

The issue of allowing manufacture for export for pharmaceuticals during an extended patent term has moved on a bit since my recent blog post and the podcast interview we did. Here...

Here are the slides from Duncan’s presentation at Medical Devices Law & Policy Conference in Sydney, Australia.  (Click here or the ‘download media’ link to the right of this page.) You...